A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese Participants

NCT05440136 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3462817 (SC)
DRUG: Placebo (SC)
DRUG: LY3462817 (IV)
DRUG: Placebo (IV)

Sponsor

Eli Lilly and Company